• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结核病与糖尿病:两种正在合并流行的疾病

Tuberculosis and diabetes mellitus: merging epidemics.

作者信息

Sen Tiyas, Joshi Shashank R, Udwadia Zarir F

机构信息

Hinduja Hospital and National Research Centre, Mahim, Mumbai, India.

出版信息

J Assoc Physicians India. 2009 May;57:399-404.

PMID:19634288
Abstract

The link between tuberculosis (TB) and diabetes mellitus (DM) has occupied the center stage of discussion. Experts have raised concern about the merging epidemics of tuberculosis and diabetes particularly in the low to medium income countries like India and China that have the highest burden of TB in the world, and are experiencing the fastest increase in the prevalence of DM. There is good evidence that DM makes a substantial contribution to TB incidence. The huge prevalence of DM in India, may be contributing to the increasing prevalence of TB. This review looks at the link between these two merging epidemics. We discuss the epidemiology, clinical features, microbiology and radiology, and management and treatment outcomes of patients with tuberculosis and diabetes mellitus.

摘要

结核病(TB)与糖尿病(DM)之间的关联一直是讨论的焦点。专家们对结核病和糖尿病这两种流行病的合并流行表示担忧,尤其是在印度和中国等中低收入国家,这些国家承担着全球最高的结核病负担,且糖尿病患病率正以最快的速度上升。有充分证据表明,糖尿病对结核病发病率有重大影响。印度糖尿病的高患病率可能是导致结核病患病率上升的原因之一。本综述探讨了这两种合并流行疾病之间的关联。我们讨论了结核病和糖尿病患者的流行病学、临床特征、微生物学和放射学,以及管理和治疗结果。

相似文献

1
Tuberculosis and diabetes mellitus: merging epidemics.结核病与糖尿病:两种正在合并流行的疾病
J Assoc Physicians India. 2009 May;57:399-404.
2
Screening and intervention of diabetes mellitus in patients with pulmonary tuberculosis in poverty zones in China: rationale and study design.中国贫困地区肺结核患者糖尿病的筛查与干预:原理与研究设计。
Diabetes Res Clin Pract. 2012 Jun;96(3):385-91. doi: 10.1016/j.diabres.2011.11.012. Epub 2011 Dec 5.
3
The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis.2型糖尿病对肺结核临床表现及治疗反应的影响。
Clin Infect Dis. 2007 Aug 15;45(4):428-35. doi: 10.1086/519841. Epub 2007 Jul 5.
4
The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis.糖尿病相关结核病的迫在眉睫的流行:从艾滋病相关结核病中吸取教训。
Int J Tuberc Lung Dis. 2011 Nov;15(11):1436-44, i. doi: 10.5588/ijtld.11.0503. Epub 2011 Sep 6.
5
Tuberculosis in Europe: a problem of drug resistance or much more?欧洲的结核病:是耐药性问题还是更复杂的问题?
Expert Rev Respir Med. 2010 Apr;4(2):189-200. doi: 10.1586/ers.10.7.
6
Pulmonary tuberculosis and diabetes mellitus--a study.肺结核与糖尿病——一项研究。
J Indian Med Assoc. 2002 Jun;100(6):376, 378-9.
7
HIV infection and multidrug-resistant tuberculosis: the perfect storm.艾滋病毒感染与耐多药结核病:完美风暴。
J Infect Dis. 2007 Aug 15;196 Suppl 1:S86-107. doi: 10.1086/518665.
8
Ancestral Mycobacterium tuberculosis genotypes in India: implications for TB control programmes.印度结核分枝杆菌的祖先基因型:对结核病控制规划的影响。
Infect Genet Evol. 2009 Jan;9(1):142-6. doi: 10.1016/j.meegid.2008.10.001. Epub 2008 Oct 17.
9
[Longitudinal assessment of IFN-gamma production in patients with pulmonary tuberculosis complicated with diabetes mellitus].[肺结核合并糖尿病患者γ-干扰素产生情况的纵向评估]
Kekkaku. 2002 May;77(5):409-13.
10
Global aspects of tuberculosis in children.儿童结核病的全球概况。
Paediatr Respir Rev. 2001 Jun;2(2):91-6. doi: 10.1053/prrv.2000.0115.

引用本文的文献

1
Immune-endocrine network in diabetes-tuberculosis nexus: does latent tuberculosis infection confer protection against meta-inflammation and insulin resistance?糖尿病-结核病关联中的免疫-内分泌网络:潜伏性结核感染是否能预防代谢炎症和胰岛素抵抗?
Front Endocrinol (Lausanne). 2024 Jan 24;15:1303338. doi: 10.3389/fendo.2024.1303338. eCollection 2024.
2
Prevalence and Associated Factors of Diabetes Mellitus Among Newly Enrolled Tuberculosis Patients in Lubumbashi (DRC).卢本巴希(刚果民主共和国)新登记结核病患者中糖尿病的患病率及相关因素
Risk Manag Healthc Policy. 2024 Jan 17;17:171-180. doi: 10.2147/RMHP.S436873. eCollection 2024.
3
Impact of diabetes itself and glycemic control status on tuberculosis.
糖尿病本身及其血糖控制状况对结核病的影响。
Front Endocrinol (Lausanne). 2023 Nov 8;14:1250001. doi: 10.3389/fendo.2023.1250001. eCollection 2023.
4
[Epidemiologic-clinical, biological and radiological features of pulmonary tuberculosis in patients with diabetes in Antananarivo, Madagascar].[马达加斯加塔那那利佛糖尿病患者肺结核的流行病学-临床、生物学及放射学特征]
Pan Afr Med J. 2022 May 18;42:49. doi: 10.11604/pamj.2022.42.49.29199. eCollection 2022.
5
Unique Reciprocal Association Seen Between Latent Tuberculosis Infection and Diabetes Is Due to Immunoendocrine Modulation (DM-LTB-1).潜伏性结核感染与糖尿病之间存在独特的相互关联,这是由于免疫内分泌调节所致(DM-LTB-1)。
Front Microbiol. 2022 Jun 27;13:884374. doi: 10.3389/fmicb.2022.884374. eCollection 2022.
6
Tuberculosis and comorbidities: treatment challenges in patients with comorbid diabetes mellitus and depression.结核病与合并症:合并糖尿病和抑郁症患者的治疗挑战
Ther Adv Infect Dis. 2022 May 20;9:20499361221095831. doi: 10.1177/20499361221095831. eCollection 2022 Jan-Dec.
7
Diabetes mellitus and its associated factors among patients with tuberculosis attending directly observed treatment centres in Oyo State, Nigeria: a cross-sectional evaluation.尼日利亚奥约州直接观察治疗中心结核病患者的糖尿病及其相关因素:一项横断面评估。
BMJ Open. 2022 Apr 1;12(4):e059260. doi: 10.1136/bmjopen-2021-059260.
8
Strategies to Combat Multi-Drug Resistance in Tuberculosis.结核病的多药耐药性防治策略。
Acc Chem Res. 2021 May 18;54(10):2361-2376. doi: 10.1021/acs.accounts.0c00878. Epub 2021 Apr 22.
9
Burden of diabetes among patients with tuberculosis: 10-year experience from a tertiary care referral teaching hospital in South India.结核病患者中的糖尿病负担:来自印度南部一家三级医疗转诊教学医院的10年经验
Lung India. 2020 May-Jun;37(3):232-237. doi: 10.4103/lungindia.lungindia_111_19.
10
Prevalence of diabetes mellitus among tuberculosis patients in Sub-Saharan Africa: a systematic review and meta-analysis of observational studies.撒哈拉以南非洲地区结核病患者中糖尿病的患病率:观察性研究的系统评价和荟萃分析。
BMC Infect Dis. 2019 Mar 13;19(1):254. doi: 10.1186/s12879-019-3892-8.